wtorek, 3 marca 2009
Sales increase by 1.6 percent to EUR 32,918 million / EBITDA before special items up 2.3 percent to EUR 6,931 million / EBIT before special items up 1.3 percent to EUR 4,342 million / Net income of EUR 1,719 million (2007: EUR 4,711
million) / Further earnings growth expected at HealthCare and CropScience in
2009 / Sharp decline in earnings forecasted for MaterialScience / Significant
reduction of net debt targeted » więcej |